Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
10/2005
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1583552A2 Antineoplastic ether lipid compounds
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092870A1 Novel benzoxazinone derivatives used as long-acting betamimetics for treating respiratory illnesses
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222216 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
10/06/2005US20050222148 Phenylaminopropanol derivatives and methods of their use
10/06/2005US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore
10/06/2005US20050222144 Medicaments for the treatment of chronic obstructive pulmonary disease
10/06/2005US20050222142 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence
10/06/2005CA2558067A1 Novel benzoxazinone derivatives used as long-acting betamimetics for treating respiratory illnesses
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951855 vascular damaging agents
09/2005
09/29/2005WO2005090282A1 Androgen receptor modulator compounds and methods
09/29/2005WO2004084843A3 Inhibitors of cathepsin s
09/29/2005US20050215786 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,,2,4-triazol-3-one
09/29/2005US20050215785 Reacting methanesulfonyl chloride with 3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid, reacting with 2-amino-3-methyl-5-chlorobenzoic acid to produce -[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]-6-chloro-8-methyl-4H-3,1-benzoxazin-4-one
09/29/2005US20050215549 TACE inhibitors
09/29/2005US20050214875 Metal chelate containing compositions for use in chemiluminescent assays
09/28/2005EP1580187A1 Apoptogenic and antiproliferative analogs of ceramide
09/28/2005CN1674907A Use of reboxetine for the treatment of hot flashes
09/28/2005CN1674906A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
09/28/2005CN1220686C Beta-hydroxy-alpha-amino acid and its derivatives and synthesizing method for preparing template
09/22/2005WO2005087754A1 Substituted morpholine and thiomorpholine derivatives
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005US20050209227 e.g. 8-{2-[2-(4-fluoro-3-trifluoromethyl-phenyl)-1,1-dimethyl-ethylamino]-1-hydroxy-ethyl}-6-hydroxy-4H-benzo [1,4]oxazin-3-one; for the treatment of inflammatory and obstructive respiratory complaints
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/21/2005EP1577306A1 novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005CN1671703A Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine
09/20/2005US6946532 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005067502A3 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005US20050202344 Method of producing ultraviolet radiation absorbent
09/14/2005EP1574504A1 Benzomorpholine derivatives
09/14/2005EP1572671A1 Non-steroidal anti-inflammatory agents
09/14/2005EP1572214A1 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
09/13/2005US6943179 Biurethane derivatives
09/13/2005US6943169 Quinolinone derivatives and uses thereof
09/09/2005WO2005082869A1 Method for the preparation of aryl ethers
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/07/2005EP1571154A1 Beta-aminoacid-derivatives as factor Xa inhibitors
09/07/2005EP1569916A1 Substituted aralkyl derivatives
09/07/2005CN1665511A Method of promoting smoking cessation
09/07/2005CN1665510A Cyclothiocarbamative derivatives as PR modulators and use thereof for treatment of skin disorders
09/06/2005US6939988 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
09/06/2005US6939964 Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
09/01/2005WO2005080339A1 Sulfonyloxy derivatives
09/01/2005WO2005037772A3 Novel ligand activating receptors rars used for human medicine and cosmetics
09/01/2005CA2557537A1 Sulfonyloxy derivatives
08/2005
08/31/2005EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
08/31/2005EP1567498A2 Mandelic acid derivatives
08/31/2005EP1567494A1 Methods for preparing phenylalkyne derivatives
08/31/2005CN1662511A Pharmaceutical salts of reboxetine
08/31/2005CN1216874C (Hetero) aryl-substituted heterocyclic enaminones, production thereof and use thereof as herbicides, acaricides and insectivides
08/30/2005US6936700 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/30/2005US6936669 copolymerizing at least one conjugated diolefin monomer and at least one functionalized monomer in an organic solvent, initiated with an anionic initiator, wherein the polymerization is conducted in the presence of an alkali alkoxide
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/25/2005WO2005077463A2 Ligand for a monoamine receptor or transporter for treating addiction or dependence
08/25/2005US20050187388 2-[ Alpha -(2-ethoxyphenoxy)benzyl]morpholine preparation; cyclization, etherification; reacting 3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylamine with chloroacetyl chloride in sodium carbonate, toluene and water; reduction, salt formation
08/25/2005US20050187110 Novel herbicides
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
08/24/2005CN1658855A O-substituted hydroxyaryl derivatives
08/23/2005US6933358 Functionalized monomers for synthesis of rubbery polymers
08/18/2005WO2005030794A3 Hemiasterlin derivatives and uses thereof
08/18/2005DE102004004731A1 Harnstoffderivate Urea derivatives
08/17/2005EP1562939A1 Carboxamides
08/17/2005EP1562918A1 Substituted benzoxazinones and uses thereof
08/17/2005EP1562917A1 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
08/17/2005EP1562603A2 Novel medicaments for the treatment of chronic obstructive pulmonary diseases
08/17/2005CN1656109A Non nucleoside reverse transcriptase inhibitors
08/17/2005CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient
08/17/2005CN1656084A Hydroxymorpholinone derivative and medicinal use thereof
08/16/2005CA2347588C An oxazinone used in preparing taxol and process for preparation thereof
08/11/2005WO2005073201A1 Urea derivatives
08/11/2005WO2005053663A3 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
08/11/2005US20050176704 Hydroxymorpholinone derivative and medicinal use thereof
08/11/2005DE102004003428A1 Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel New long-acting beta-2-agonists, and their use as medicaments
08/11/2005CA2554911A1 Urea derivatives
08/10/2005EP1560574A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
08/10/2005EP1395570B1 Oxazin(thi)one compounds used as fungicides
08/10/2005CN1653054A Benzoxazine derivatives as 5-HT6 modulators and uses thereof
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652768A 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replaceme
08/10/2005CN1214018C Morpholinones as light stabilizers
08/04/2005WO2005070908A1 Novel long-working beta-2-agonists and use thereof as medicaments
08/04/2005WO2005070872A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists
08/04/2005US20050171154 Carboxylic acid amides
08/04/2005US20050171102 Semicarbazide derivatives for combating thromboembolic diseases
08/04/2005CA2552784A1 Beta-2-agonists, and their use as medicaments
08/04/2005CA2551821A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists
08/03/2005EP1559717A2 Oxabispidine compounds useful in the treatment of cardiac arrythmias
08/03/2005CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 112